Texas Judge Hears Case to End Federal Approval of Abortion Pill
In a televised courtroom hearing on Tuesday, a Texas judge heard arguments against the federal approval of medication abortion drugs. The case was brought forth by a coalition of conservative groups who claim that the drugs, which can be taken up to 10 weeks into a pregnancy, are unsafe and should not be approved by the FDA.
During the hearing, the judge questioned the safety of the drugs and hinted at his personal bias against abortion. “I don’t understand how people can take these drugs and not be affected by them,” he said. His comments sparked concern among pro-choice advocates, who worry that his bias will influence his decision.
The hearing comes as conservatives across the country are pushing to block access to medical abortion pills. In California, a group of lawmakers are proposing a bill that would require women to visit a doctor in person in order to receive the pill, effectively limiting access to those who live in rural areas or cannot afford to take time off work to visit a medical provider.
Pro-choice advocates have condemned these efforts, arguing that they are an attack on women’s reproductive rights. “These attacks on medication abortion are part of a larger agenda to restrict access to abortion care and control women’s bodies,” said Nancy Northup, president and CEO of the Center for Reproductive Rights.
The judge’s decision on the case is expected in the coming weeks.
NYLI MacKay High Income ETF Q1 2025 Commentary Reveals Surprising Trends That Could Change Your Investment Strategy!
New York – The NYLI MacKay High Income ETF delivered a compelling performance during the first quarter of 2025, reflecting the dynamic shifts in the fixed income market. Investors closely monitored the evolving economic landscape as interest rates and inflation rates influenced market behavior. As the Federal Reserve continued its efforts to combat inflation through rate adjustments, many fixed-income assets experienced volatility. The NYLI MacKay ETF navigated these fluctuations while strategically positioning its portfolio to capture potential gains. The fund’s allocation strategy emphasized sectors that ... Read more